{
    "clinical_study": {
        "@rank": "95842", 
        "arm_group": [
            {
                "arm_group_label": "Fontan Patients", 
                "arm_group_type": "Experimental", 
                "description": "Fontan patients who are monitored at the Hospital for Sick Children (SickKids) will undergo an exercise program"
            }, 
            {
                "arm_group_label": "Healthy Controls", 
                "arm_group_type": "No Intervention", 
                "description": "Healthy age-matched adolescents"
            }
        ], 
        "brief_summary": {
            "textblock": "Primary Objective:  To determine if impairments in cardiac and musculoskeletal function and\n      metabolism exist in Fontan children.\n\n      Secondary Objectives:\n\n        1. To determine if impairments do exist, are they related to exercise capacity.\n\n        2. To determine if a 12-week exercise training intervention improves cardiac and/or\n           musculoskeletal metabolism.\n\n      Hypothesis: The investigators hypothesize that abnormalities in cardiac and skeletal\n      function are evident, influence exercise capacity, and can be improved with exercise\n      training."
        }, 
        "brief_title": "Mechanisms of Dysfunction and the Influence of Exercise on Cardiac and Musculoskeletal Function", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Congenital Heart Disease", 
        "condition_browse": {
            "mesh_term": [
                "Heart Diseases", 
                "Heart Defects, Congenital"
            ]
        }, 
        "detailed_description": {
            "textblock": "This proposed research provides an interdisciplinary approach to understanding exercise\n      intolerance by examining cardiac and musculoskeletal metabolism in a unique cohort of\n      children with congenital heart disease.  Study findings may more importantly lead to\n      evidence-based exercise interventions that promote improvements in overall physical health,\n      quality of life, and functional status for Fontan children. Furthermore, this pilot study\n      will lead to the development of a novel research protocol which may be applied to larger\n      Fontan and other congenital heart disease cohorts. This study will also provide preliminary\n      data to develop and conduct a larger clinical research project."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Fontan Patients:\n\n          1. Patients who have had the Fontan cardiac procedure\n\n          2. 10-16 years of age\n\n          3. Written Informed Consent\n\n        Healthy Controls:\n\n          1. 10 - 16  years of age\n\n          2. Written Informed Consent\n\n        Exclusion Criteria:\n\n        Fontan Patients:\n\n          1. Contraindication to exercise\n\n          2. Physically active (i.e., \u2265 60 minute of moderate-vigorous activity) (Strong et al.,\n             2005)\n\n          3. Patients in whom MRI is contraindicated (e.g. pacemaker, ocular metal,\n             claustrophobia, tattoos)\n\n          4. Patients with a known allergy to gadolinium.\n\n          5. Patients with a history of allergic disposition or have anaphylactic reactions\n\n          6. Moderate-to-severe renal impairment (defined as having a GFR/ eGFR < 60 mL/min)\n\n          7. Have Sickle Cell anemia\n\n          8. Known pregnancy, or breast feeding\n\n          9. Patient is uncooperative during a MRI without sedation or anesthesia\n\n        Healthy Controls:\n\n          1. Contraindication to exercise\n\n          2. Physically active (i.e., \u2265 60 minute of moderate-vigorous activity) (Strong et al.,\n             2005)\n\n          3. Patients in whom MRI is contraindicated (e.g. pacemaker, ocular metal,\n             claustrophobia, tattoos, pregnancy)\n\n          4. Patient is uncooperative during a MRI without sedation or anesthesia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "16 Years", 
            "minimum_age": "10 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02004756", 
            "org_study_id": "1000016650"
        }, 
        "intervention": {
            "arm_group_label": "Fontan Patients", 
            "description": "The Fontan cohort will subsequently complete a 12-week moderate intensity exercise intervention whereby individualized activity-based home interventions will be prescribed (i.e., sample activities: walking, jogging, swimming, cycling, soccer). More specifically, individualized weekly exercise programs for participants will be provided incorporating two specific exercise components.", 
            "intervention_name": "Exercise Program", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pediatric", 
            "fontan", 
            "congenital heart disease", 
            "cardiac and musculoskeletal funion", 
            "cardiac and/or musculoskeletal metabolism", 
            "exercise training intervention"
        ], 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5V1X8"
                }, 
                "name": "The Hospital for Sick Children"
            }, 
            "investigator": [
                {
                    "last_name": "Brian McCrindle, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Gregory Wells, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Paul Babyn, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Shi-Joon Yoo, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Luc Mertens, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Laura Banks", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Mechanisms of Dysfunction and the Influence of Exercise on Cardiac and Musculoskeletal Function in Children After the Fontan Procedure", 
        "overall_contact": {
            "email": "laura.banks@sickkids.ca", 
            "last_name": "Laura Banks", 
            "phone": "416-813-7617"
        }, 
        "overall_official": {
            "affiliation": "The Hospital for Sick Children", 
            "last_name": "Brian McCrindle, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Blood oxygen level dependent functional magnetic resonance imaging (BOLD fMRI), and 31P-MRS will allow for the precise measurement of cardiac and musculoskeletal function, circulatory perfusion and vascular reactivity, and aerobic and anaerobic metabolism, respectively. Cardiac function will be examined via MRI and exercise echocardiography.", 
            "measure": "Cardiac and skeletal function and metabolism", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02004756"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Hospital for Sick Children", 
            "investigator_full_name": "Brian McCrindle", 
            "investigator_title": "Staff Cardiologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "The Hospital for Sick Children", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Hospital for Sick Children", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}